Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 275 for “"P-gp"”.

  1. Influence of inflammation on the pharmacokinetics of fexofenadine, a P-gp and Oatp substrate

    … inflammation on fexofenadine, a substrate of P-gp and Oatp, pharmacokinetics (PK) in rats. A pilot study was conducted to ensure that the housing environment, particularly changes in bedding, did not affect fexofenadine PK. A period of acclimatization of 2-3 days was sufficient to prevent …

    adelaide Repository record for Influence of inflammation on the pharmacokinetics of fexofenadine, a P-gp and Oatp substrate (opens in a new tab)

  2. Protein kinase inhibitor effects on P-glycoprotein (P-gp) activity and expression in various cell lines

    … on expression and activity of P-glycoprotein (P-gp). A protein kinase inhibitor (PKI) library was screened, to determine its effects on activity and expression of P-gp, in various cell lines. Cell lines were incubated with PKI for 24 h. Subsequent P-gp substrate accumulation studies were …

    manitoba Repository record for Protein kinase inhibitor effects on P-glycoprotein (P-gp) activity and expression in various cell lines (opens in a new tab)

  3. Impact of CYP3A4/P-gp interacting medications on clinical outcomes in nonvalvular atrial fibrillation patients managed on rivaroxaban

    … rivaroxaban with concurrent exposure to CYP3A4/P-gp interacting medications were placed in the concomitant interacting medication (CIM) user group, and those without exposure to CYP3A4/P-gp interacting medications were placed in the CIM non-user group. Patients were excluded if they did not have …

    texas Repository record for Impact of CYP3A4/P-gp interacting medications on clinical outcomes in nonvalvular atrial fibrillation patients managed on rivaroxaban (opens in a new tab)

  4. Design and evaluation of novel PET and SPECT tracers for imaging the monoamine system and the P-gp transporter

    … elements, being the monoamine system and the P-gp transporter, were developed and evaluated in vivo. The first objective of this thesis was the design of radiotracers for the monoamine system more specifically, the norepinephrine transporter, monoamine oxidase and dopamine transporter which are …

    ghent Repository record for Design and evaluation of novel PET and SPECT tracers for imaging the monoamine system and the P-gp transporter (opens in a new tab)

  5. The Regulation of Multidrug Resistance Phosphoglycoprotein (MDR1/P-gp) and Breast Cancer Resistance Protein (BCRP) in the Human Placenta

    Multidrug resistance phosphoglycoprotein (MDR1/P-gp) and breast cancer resistance protein (BCRP) were first isolated in chemoresistant cancer cells and have since been found in a variety of normal tissue, including the placenta. The potential function of MDR1/P-gp and BCRP in the human placenta is …

    ottawa-retro Repository record for The Regulation of Multidrug Resistance Phosphoglycoprotein (MDR1/P-gp) and Breast Cancer Resistance Protein (BCRP) in the Human Placenta (opens in a new tab)

  6. Role of gastrointestinal multidrug resistance (MDR1) gene and P-glycoprotein (P-gp) in the oral absorption of methadone in horses

    Methadone is a mu-opioid receptor agonist which is a very effective analgesic used to treat moderate to severe acute and chronic pain in humans. Due to methadone’s minimal undesirable side-effects in people, we believed it could be of use in horses as an analgesic agent. As found with the majority …

    lsu-thes Repository record for Role of gastrointestinal multidrug resistance (MDR1) gene and P-glycoprotein (P-gp) in the oral absorption of methadone in horses (opens in a new tab)

  7. In vitro interactions of natural health products with P-glycoprotein (P-gp) and cytochrome P450 3A4 (CYP3A4): Relevance to HIV therapies

    … or the xenobiotic efflux pump P-glycoprotein (P-gp). NHPs and drugs relevant to HIV were assessed for their ability to affect these drug disposition pathways. NHP extracts were examined for their ability to inhibit CYP3A4 and stimulate P-gP ATPase. Goldenseal (GS) NHPs were the most inhibitory of …

    ottawa-retro Repository record for In vitro interactions of natural health products with P-glycoprotein (P-gp) and cytochrome P450 3A4 (CYP3A4): Relevance to HIV therapies (opens in a new tab)

  8. Regulation of P-glycoprotein and ABCP transporters

    … however its effect on P-glycoprotein (P-gp) and ABC transporter in placenta (ABCP) levels in placenta is not known. In-vitro studies in hepatocytes have reported induction of P-gp mRNA by some polycyclic aromatic hydrocarbons. To examine whether smoking can affect placental P-gp and ABCP, …

    wvu Repository record for Regulation of P-glycoprotein and ABCP transporters (opens in a new tab)

  9. Generation of chimeric P-glycoprotein for functional and structural investigations

    … A notorious mediator of MDR is P-glycoprotein (P-gp, ABCB1), product of the human <em>MDR1</em> gene, which actively effluxes cytotoxic drugs from cancer cells, resulting in sub-therapeutic intracellular concentrations. Understanding how P-gp interacts with drugs has been severely limited by the …

    oxford Repository record for Generation of chimeric P-glycoprotein for functional and structural investigations (opens in a new tab)

  10. P-Glycoprotein-associated Anthracycline Resistance In B-CLL: Potential For Cytokine Modulation

    … is generally associated with P-glycoprotein (P-gp) expression and presents an obstacle to successful chemotherapy. Attempts to overcome P-gp-associated MDR using P-gp modulators, such as verapamil, have been hindered by their intrinsic in vivo toxicity. In 1991, however, Scala et al. …

    plymouth Repository record for P-Glycoprotein-associated Anthracycline Resistance In B-CLL: Potential For Cytokine Modulation (opens in a new tab)

  11. The role of P-glycoprotein in host-pathogen interactions

    P-glycoprotein (P-gp) is an exceptional membrane transporter because of its ability to carry a large variety of compounds across the plasma membrane. Thanks to this substrate promiscuity, P-gp over-expression is responsible for multidrug resistance (MDR) in a variety of cells from microorganisms to …

    zurich

  12. P-Glycoprotein Expression in Canine Lymphomas

    P-glycoprotein (P-gp) is a membrane glycoprotein which can act as an efflux pump for certain chemotherapeutic drugs and thereby confers resistance to these drugs on the host cell. The P-gp isoform encoded by the human mdrl gene has been implicated as a factor in clinical resistance in human …

    glasgow Download PDF for P-Glycoprotein Expression in Canine Lymphomas (opens in a new tab)

  13. Contribution of p-glycoprotein mediated-efflux to the epithelial transport of amphotericin b in caco-2 cells

    … such as the ABCB1 gene product P-glycoprotein (P-gp), affect the oral bioavailability and disposition of a diverse range of compounds. It remains to be ascertained whether AmB is a substrate of P-gp mediated efflux. Therefore, the objective of this study was to determine whether P-gp contributes …

    ubc Repository record for Contribution of p-glycoprotein mediated-efflux to the epithelial transport of amphotericin b in caco-2 cells (opens in a new tab) Download PDF for Contribution of p-glycoprotein mediated-efflux to the epithelial transport of amphotericin b in caco-2 cells (opens in a new tab)

  14. Role of P-Glycoprotein in Alzheimer’s Disease for Enhanced Brain Elimination of Amyloid-β

    … the blood-brain barrier (BBB). P-glycoprotein (P-gp) is a membrane-bound efflux protein located on the apical, or blood, side of the BBB, which transports a wide variety of substrates. Further complicating this potential clearance mechanism is the reduction of P-gp cell surface expression in …

    south-carolina Repository record for Role of P-Glycoprotein in Alzheimer’s Disease for Enhanced Brain Elimination of Amyloid-β (opens in a new tab)

  15. Characterization of Cucurbitacin-Inspired Estrone Analogues as Novel Inhibitors of Human ATP- Binding Cassette Proteins (ABCB1 and ABCC1)

    … across membrane barriers. P-glycoprotein (P-gp/ ABCB1) and Multidrug Resistance protein 1 (MRP1/ABCC1) are widely reported ABC transporters associated with multidrug resistance in cancer. Multidrug resistance (MDR) mediated by P-gp and MRP1 is responsible for treatment failures of many …

    sdstate Repository record for Characterization of Cucurbitacin-Inspired Estrone Analogues as Novel Inhibitors of Human ATP- Binding Cassette Proteins (ABCB1 and ABCC1) (opens in a new tab)

  16. Placental P-glycoprotein: Role in disposition of medications administered during pregnancy

    … placental efflux transporter P-glycoprotein (P-gp) and its role in regulating the placental distribution of medications used during pregnancy. P-gp expression and transport activity were defined in brush border membrane vesicles prepared from human placenta of various gestational ages. The …

    utmb Repository record for Placental P-glycoprotein: Role in disposition of medications administered during pregnancy (opens in a new tab)

  17. TARGETING CELLULAR METABOLISM BY LEVERAGING THE PHOTOSENSITIZER VERTEPORFIN TO OVERCOME CANCER MULTIDRUG RESISTANCE

    … outcomes for cancer patients. P-glycoprotein (P-gp) is an ATP-binding cassette (ABC) drug transporter that effectively translocates substrates (chemotherapeutics in this context) from cancer cells, thus reducing their efficacy over time. Chemoresistance is responsible for approximately 90% of …

    maryland Repository record for TARGETING CELLULAR METABOLISM BY LEVERAGING THE PHOTOSENSITIZER VERTEPORFIN TO OVERCOME CANCER MULTIDRUG RESISTANCE (opens in a new tab)

Page 1 of 14